Biochemical Assays Pharma Companies Small Molecule 
Drug Discovery World
SEPTEMBER 29, 2022
The company has narrowed down their decision to three options: Option #1: Company Z performs the project internally and screens their in-house collection of 250,000 small molecules using a traditional fluorescence-based biochemical assay. protein-protein or small molecule-target interactions).
PerkinElmer
FEBRUARY 18, 2021
Small screens are better than large ones. Biochemical assays have the highest success rate. That is not what PerkinElmer found in a comprehensive survey of leaders at the top 20 Pharma, ranked for R&D spending. By a 3:1 margin, PerkinElmer found top Pharma screens for a specific target. Biologics are booming.
Expert insights. Personalized for you.
130 
Let's personalize your content